BerGenBio

Selective AXL inhibitors

Home  /  Media Center  /  Events

Events

ALLPAST EVENTSUPCOMING EVENTS

  Q1 2022 Results May 24, 2022

Read More
May 24, 2022 Online

  Annual General Meeting April 28th

Read More
Apr 28, 2022 Online

BERGENBIO ASA: Invitation to THIRD quarter 2021 results

A webcast presentation by BerGenBio’s senior management team will take place Tuesday 16th November 2021…

Read More
Nov 16, 2021 Online

BERGENBIO ASA: Invitation to PRESENTATION OF SECOND quarter and HALF YEAR 2021 results

August 17, 2021 A webcast presentation by BerGenBio’s senior management team will take place Tuesday…

Read More
Aug 17, 2021 Online

BERGENBIO TO PRESENT AT ABGSC SEMINAR

Bergen, Norway, 21st May 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for…

Read More
May 21, 2021 Online

BERGENBIO ASA: Invitation to FIRST quarter 2021 results

A webcast presentation by BerGenBio’s senior management team will take place Wednesday 19th May 2021…

Read More
May 19, 2021 Online

Subscribe to our newsletter

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.